Company Performance Metrics
- Andrzej Kosior: Co-Founder and Scientist
- Kryspin Mirota: Founder and Scientist
What we do: LifeFlow is a MedTech startup specializing in cardiac diagnostics. It is one of the 2 companies worldwide which have developed a technology enabling non-invasive assessment of the functional significance of coronary artery lesions based on numerical simulations of blood flow using CFD methods (Computational Fluid Dynamics).
Market
need: Every year 2,5 mln people in Europe are diagnosed with the coronary heart disease (CHD). CHD is the cause of every fifth dead in development countries. Coronary artery disease, a leading cause of CHD, nowadays is diagnosed using Coronary angiography. These procedures are expensive, invasive and risky for the patient. The estimated, yearly market potential for LifeFlow diagnostic is 1 mln services in Europe and 1.25 mln services in the US.
Solution: LifeFlow technology iSIL-FFR (in SILico FFR), is a post-processing software run as Software as a Service (SaaS) in the cloud for non-invasive assessment of the functional significance of coronary artery lesions based on a three-dimensional reconstruction of the lumen of the coronary arteries from static CCTA and numerical simulations of blood flow in reconstructed vessels.
